Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 680 results found. Search for [ Oxford university ]

Results 1 to 21 of 680
PTI
March 7, 2021
This is something very special and I see it myself because I'm on weekly teleconferences with our colleagues in India, you make a recommendation, and within days it's done and not only done, but it's done well and with incredible rigor and thought and creativity, Dr Hotez said


Associated Press
March 6, 2021
Nadhim Zahawi, in an interview with The Associated Press, confirmed reports that the Serum Institute of India, one of the world's largest vaccine makers, would be sending doses of the vaccine developed by Oxford University and AstraZeneca to the UK


BusinessToday.In
March 5, 2021
Biden administration recently decided to enforce Defence Production Act, which allowed it to boost vaccine production by blocking export of raw material supplies to other countries


Reuters
March 4, 2021
Government data shows that only 10% of about 12.6 million people immunised in India have taken the COVAXIN shot, which was found to be 81% effective in an interim analysis of the late-stage trial, its developer Bharat Biotech said


PB Jayakumar
March 3, 2021
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy


Rashi Bisaria
New Delhi, March 3, 2021
India's fuel demand to rise 9.8% in year to March 2022 India's fuel consumption could rise by 9.8% in the year to March 2022, its highest pace of growth in six years, driven by robust demand for gasoline and gasoil in Asia's third largest economy, according to initial government projections. Higher expectation of fuel consumption, a proxy for oil demand, points to a sharp recovery in industrial activity in the economy hit hard by the pandemic. Economic recovery lost steam in Jan-Feb: Axis...


Reuters
March 3, 2021
\"The UK has ordered 100 million doses of AstraZeneca's COVID-19 vaccine, of which 10 million doses will come from the Serum Institute of India,\" a UK government spokesperson told Reuters


BusinessToday.In
March 2, 2021
As senior citizens across the country take part in the vaccination drive, here is all the information they need two know about the two vaccines - Covaxin and Covishield


BusinessToday.In
March 1, 2021
The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states


Reuters
March 1, 2021
AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca-Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic, the report added


Reuters
February 25, 2021
India has vaccinated more than 10.5 million health and front-line workers since beginning its immunisation campaign on January 16


PTI
February 25, 2021
Located in the city of Pune in Maharashtra, the SII is the world's largest vaccine manufacturer by volume


PTI
February 20, 2021
According to the researchers, the dosage regimen is beneficial while vaccine supplies are initially limited


Reuters
February 19, 2021
Symptoms, as reported in clinical trials for the AstraZeneca shot, can include a high temperature or headache and are a normal sign that the body is generating an immune response


PTI
February 17, 2021
The vaccines currently approved for emergency use in India are Covishield, from the Oxford-AstraZeneca stable manufactured by Pune's Serum Institute of India, and Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV)


Reuters
February 17, 2021
Having reported the highest number of coronavirus infections after the United States, and with the world's biggest vaccine-making capacity, India says it has been the fastest to reach many inoculation milestones


Reuters
February 16, 2021
AstraZeneca has said its vaccine appeared to offer only limited protection against mild disease caused by the South African variant


BusinessToday.In
February 16, 2021
Serum Institute has applied for registration with Health Canada with the help of Toronto-based Verity Pharmaceuticals, Adar Poonawalla said


Reuters
February 12, 2021
In India, we are fortunate that supply of vaccines is not a rate-limiting step, but to meet the timelines set by the government, we will have to immunise somewhere between 4 and 5 times more people each day than we are doing today, says Gagandeep Kang of Christian Medical College in Vellore


BusinessToday.In
February 12, 2021
Chhattisgarh CM had raised two primary concerns regarding Covaxin -- inhibitions on incomplete trials and absence of \"expiration date\". Dr Vardhan says vaccine approved after due evaluation of pre-clinical and clinical trial data and that expiry date is mentioned on its label


PAGES 1 OF 34  12345